Coquilla, Rizza H.

HRN: 29-46-81  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/12/2026
CEFTRIAXONE 1G (VIAL)
08/12/2026
08/19/2026
IVT
1g
Q12
T/C CNSI
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Central Nervous System    Compliance to guidelines: Compliant To Guidelines